AHMED NADIM 4
4 · Cullinan Therapeutics, Inc. · Filed Feb 25, 2026
Insider Transaction Report
Form 4
AHMED NADIM
DirectorPresident and CEO
Transactions
- Sale
Common Stock
[F1]2026-02-24$14.47/sh−13,515$195,562→ 390,803 total
Footnotes (1)
- [F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact|2026-02-25